Showing results (21-30 of 25) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Nature Cancer|April 3, 2025
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA studyGuillaume Cartron, Roch Houot, Yassine Al Tabaa, et al.Journal of Hematology & Oncology|July 3, 2026
Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control armGuillaume Cartron, Isabelle Chaillol, Roch Houot, et al.Blood Advances|January 9, 2026
Health-related quality of life after second-line Axi-cel in transplant-ineligible patients with large B-cell lymphomaEmilie Charton, Amélie Anota, Emmannuel Bachy, et al.Nature Medicine|September 14, 2023
Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trialRoch Houot, Emmanuel Bachy, Guillaume Cartron, et al.European Journal of Cancer (Oxford, England : 1990)|December 6, 2025
Large B-cell lymphoma: The LYSA pragmatic guidelinesPierre Sesques, Guillaume Manson, Sydney Dubois, et al.Pageof 3